Virtu KCG Holdings’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$152K Buy
+5,631
New +$139K ﹤0.01% 2286
2016
Q2
Sell
-4,066
Closed -$178K 3211
2016
Q1
$178K Buy
+4,066
New +$158K 0.01% 2144
2015
Q4
Sell
-834
Closed -$20K 3795
2015
Q3
$20K Sell
834
-1,635
-66% -$43.3K ﹤0.01% 3154
2015
Q2
$85K Buy
2,469
+523
+27% +$19.9K ﹤0.01% 2959
2015
Q1
$88K Sell
1,946
-8,114
-81% -$433K ﹤0.01% 2684
2014
Q4
$547K Buy
10,060
+9,072
+918% +$601K 0.01% 1570
2014
Q3
$59K Buy
+988
New +$77.6K ﹤0.01% 3315
2014
Q2
Sell
-4,732
Closed -$303K 3934
2014
Q1
$303K Buy
4,732
+2,067
+78% +$177K ﹤0.01% 2500
2013
Q4
$255K Buy
+2,665
New +$274K ﹤0.01% 2822

Other funds holding NNVC

Virtu KCG Holdings's NNVC Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in NanoViricides (NNVC) in Q2 2017: 5,631 shares worth $152K. The stake represents ﹤0.01% of the portfolio and ranks #2286 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in NNVC as recently as Q1 2016.

Virtu KCG Holdings first reported a position in NNVC in Q4 2013 and has held it in 9 quarters since. The position peaked at $547K in Q4 2014. 44 funds tracked by Wall St. Rank hold NNVC as of Q2 2017.

  • Virtu KCG Holdings held 5,631 shares of NanoViricides worth $152K as of Q2 2017.
  • NanoViricides was a new Virtu KCG Holdings position in Q2 2017.
  • NanoViricides made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2286 holding.
  • Virtu KCG Holdings first reported a position in NanoViricides in Q4 2013 and has held it in 9 quarters since.
  • Virtu KCG Holdings's NanoViricides position peaked at $547K in Q4 2014.
  • 44 funds tracked by Wall St. Rank held NanoViricides as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.